Longevity Health Holdings Inc. (XAGE) は上場企業です ヘルスケア セクターの バイオテクノロジー 業界で事業展開. 本社所在地は Pittsburgh, PA, アメリカ. 現CEOは J. Ram Ajjarapu.
XAGE を有する IPO日 2021-09-23, 15 名の正社員, に上場 Other OTC, 時価総額 $528.95K.
Longevity Health Holdings Inc focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.
